Evidence map›Paper›PMID 39399559›Full record

ArticleNeurology. Clinical practice2025

Individualized Neuroprognostication in Neonates With Hypoxic-Ischemic Encephalopathy Treated With Hypothermia.

Andrea Van Steenis, Mehmet N Cizmeci, Floris Groenendaal, Marianne Thoresen, Frances M Cowan, Linda S de Vries, Sylke J Steggerda

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrea Van SteenisWillem-Alexander Children's Hospital (AVS, LSV, SJS), Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, the Netherlands; Department of Pediatrics (MNC), Division of Neonatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Neonatology (FG), University Medical Center Utrecht and Utrecht University, Netherlands; Division of Neonatal Neuroscience (MT, FMC), Translational Health Sciences, Bristol Medical School, University of Bristol; and Department of Pediatrics and Neonatal Medicine (FMC), Imperial College, London, United Kingdom.ORCID https://orcid.org/0000-0002-0549-7066
Mehmet N CizmeciWillem-Alexander Children's Hospital (AVS, LSV, SJS), Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, the Netherlands; Department of Pediatrics (MNC), Division of Neonatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Neonatology (FG), University Medical Center Utrecht and Utrecht University, Netherlands; Division of Neonatal Neuroscience (MT, FMC), Translational Health Sciences, Bristol Medical School, University of Bristol; and Department of Pediatrics and Neonatal Medicine (FMC), Imperial College, London, United Kingdom.ORCID https://orcid.org/0000-0001-6807-4266
Floris GroenendaalWillem-Alexander Children's Hospital (AVS, LSV, SJS), Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, the Netherlands; Department of Pediatrics (MNC), Division of Neonatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Neonatology (FG), University Medical Center Utrecht and Utrecht University, Netherlands; Division of Neonatal Neuroscience (MT, FMC), Translational Health Sciences, Bristol Medical School, University of Bristol; and Department of Pediatrics and Neonatal Medicine (FMC), Imperial College, London, United Kingdom.ORCID https://orcid.org/0000-0002-9284-1637
Marianne ThoresenWillem-Alexander Children's Hospital (AVS, LSV, SJS), Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, the Netherlands; Department of Pediatrics (MNC), Division of Neonatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Neonatology (FG), University Medical Center Utrecht and Utrecht University, Netherlands; Division of Neonatal Neuroscience (MT, FMC), Translational Health Sciences, Bristol Medical School, University of Bristol; and Department of Pediatrics and Neonatal Medicine (FMC), Imperial College, London, United Kingdom.ORCID https://orcid.org/0000-0002-9615-9109
Frances M CowanWillem-Alexander Children's Hospital (AVS, LSV, SJS), Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, the Netherlands; Department of Pediatrics (MNC), Division of Neonatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Neonatology (FG), University Medical Center Utrecht and Utrecht University, Netherlands; Division of Neonatal Neuroscience (MT, FMC), Translational Health Sciences, Bristol Medical School, University of Bristol; and Department of Pediatrics and Neonatal Medicine (FMC), Imperial College, London, United Kingdom.ORCID https://orcid.org/0000-0003-2679-7137
Linda S de VriesWillem-Alexander Children's Hospital (AVS, LSV, SJS), Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, the Netherlands; Department of Pediatrics (MNC), Division of Neonatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Neonatology (FG), University Medical Center Utrecht and Utrecht University, Netherlands; Division of Neonatal Neuroscience (MT, FMC), Translational Health Sciences, Bristol Medical School, University of Bristol; and Department of Pediatrics and Neonatal Medicine (FMC), Imperial College, London, United Kingdom.ORCID https://orcid.org/0000-0002-7282-8304
Sylke J SteggerdaWillem-Alexander Children's Hospital (AVS, LSV, SJS), Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, the Netherlands; Department of Pediatrics (MNC), Division of Neonatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Neonatology (FG), University Medical Center Utrecht and Utrecht University, Netherlands; Division of Neonatal Neuroscience (MT, FMC), Translational Health Sciences, Bristol Medical School, University of Bristol; and Department of Pediatrics and Neonatal Medicine (FMC), Imperial College, London, United Kingdom.ORCID https://orcid.org/0000-0002-5603-5697

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: To determine whether post-rewarming brain MRI enables individualized domain-specific prediction of neurodevelopmental outcomes at 2 years of age in infants treated with hypothermia for hypoxic-ischemic brain injury. Methods: We conducted a retrospective multicenter study of infants with moderate-to-severe hypoxic-ischemic encephalopathy (HIE) treated with hypothermia. Brain MRI abnormalities and the prediction of domain-specific 2-year neurodevelopmental outcomes were scored independently by 2 investigators after which consensus was reached for both imaging findings and outcome prediction. Neuroimaging patterns were categorized as normal, white matter (WM)/watershed-predominant, deep gray matter (DGM)-predominant, and near-total injury. Outcomes were predicted separately for mortality, cerebral palsy (CP) type and severity, cognitive delay, epilepsy, cerebral visual impairment (CVI), and feeding difficulties; these outcomes were predicted as highly unlikely, possible, probable, or highly likely. Results: Of the 152 study infants, 27 (18%) died. The neurodevelopmental outcome at 2 years was available in all 125 survivors. CP was seen in 21 of 125 surviving infants (17%). No infants in the highly unlikely category developed CP while 90% in the highly likely category did. When CP was predicted as possible, 40% developed CP; all were mild and ambulatory. When CP was predicted as probable, 67% developed CP of whom 40% were severe and nonambulatory. Cognitive scores were available in 104 of 125 infants (83%). Cognitive delay was seen in 23 of 104 infants (22%) (15% mild and 7% severe). When cognitive delay was predicted as highly unlikely, 92% did not develop cognitive delay and the delay was mild in those who did. When cognitive delay was considered highly likely, this developed in 100%. When epilepsy, CVI, and feeding problems were predicted as highly unlikely, 98% did not develop epilepsy; for CVI and feeding problems, this was 100% and 97%, respectively. In 27 of 152 infants (18%), the investigators reached consensus that the overall injury was severe enough to consider redirection of care; 21 of 27 infants (78%) died. Of the survivors, 5 infants developed severe CP and 1 had a mild dyskinetic CP with swallowing problems and CVI. Discussion: Individualized domain-specific categorical neuroprognostication mainly based on brain MRI is feasible, reliable, and highly accurate in infants with HIE.

Identifiers

PMID39399559
PMCPMC11464227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.